3002.15.00.11/Biosimilar Trastuzumab Injection/Canada

Biosimilar Trastuzumab Injection from Canada

Biosimilar version of trastuzumab monoclonal antibody for HER2 cancers. HTS 3002.15.00.11 as interchangeable immunological product.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Distinguish from originator with biosimilar docs

Biosimilar Trastuzumab Injection from Canada — Import Duty Rate | HTS 3002.15.00.11